Forget Ozempic: This High-Flying Device Maker Stands Strong
In a world obsessed with weight-loss drugs, a different growth engine quietly powers ahead. This article explains why...
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articlesIn a world obsessed with weight-loss drugs, a different growth engine quietly powers ahead. This article explains why...
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...
Robinhood Chain is igniting a wave of ETH onboarding that could reshape demand for Ethereum. With $843k in on-chain u...
Anthropic's $200 million DoD contract is under scrutiny after reports about Claude's deployment in a January raid. Th...
Worries about the economy are common, especially when loans loom large. This guide breaks down practical steps you ca...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
A trio of midstream dividend ETFs yielding more than 5% are delivering market-beating performance, offering both inco...
A broad study shows younger adults delaying key life events, pressuring insurers to rethink offerings as 'living bene...
Jeanette Cutler steps in as Chief Marketing Officer at Baird & Warner, bringing global brand leadership from Beam Sun...
Healthcare REITs offer income, but they carry unique risks. Learn how to evaluate Medical Properties Trust with actio...
Nvidia posted solid earnings as hyperscalers accelerate AI builds. CFO Colette Kress flagged rising GPU rental costs,...
Cybersecurity shares jumped after inflation data cooled, lifting risk sentiment. CrowdStrike climbs 11% and Palo Alto...